This week, the United States and China continued to take action on commitments made during the leaders’ meeting in October.
At an estimated market size of RMB 20 billion in 2018, China’s medical artificial intelligence (AI) market promises vast opportunities for US companies with innovative AI products and solutions. Yet, businesses that do not have the foresight and resources to deal with complex regulatory challenges may struggle to thrive in this competitive market. If US companies want to succeed, they must position themselves strategically and mitigate regulatory risks through clever partnerships and targeted policy advocacy.
This week, we chat with Jake Parker in Beijing to get an update on a range of issues. Up first, a spate of drafts are available for comments on cybersecurity and personal information transfer and you can find links below.
Intellectual property rights and protections are a major issue in China, especially for foreign businesses. How have understandings of intellectual property in the country evolved over the decades? To get an answer, we spoke with Chynna Hawes, who is a
